Nematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection.
Burkholderia pseudomallei, the causative agent of melioidosis, is among a growing number of bacterial pathogens that are increasingly antibiotic resistant. Antimicrobial peptides (AMPs) have been investigated as an alternative approach to treat microbial infections, as generally, there is a lower likelihood that a pathogen will develop resistance to AMPs. In this study, 36 candidate Caenorhabditis elegans genes that encode secreted peptides of <150 amino acids and previously shown to be overexpressed during infection by B. pseudomallei were identified from the expression profile of infected nematodes. RNA interference (RNAi)-based knockdown of 12/34 peptide-encoding genes resulted in enhanced nematode susceptibility to B. pseudomallei without affecting worm fitness. A microdilution test demonstrated that two peptides, NLP-31 and Y43C5A.3, exhibited anti-B. pseudomallei activity in a dose dependent manner on different pathogens. Time kill analysis proposed that these peptides were bacteriostatic against B. pseudomallei at concentrations up to 8× MIC90. The SYTOX green assay demonstrated that NLP-31 and Y43C5A.3 did not disrupt the B. pseudomallei membrane. Instead, gel retardation assays revealed that both peptides were able to bind to DNA and interfere with bacterial viability. In parallel, microscopic examination showed induction of cellular filamentation, a hallmark of DNA synthesis inhibition, of NLP-31 and Y43C5A.3 treated cells. In addition, the peptides also regulated the expression of inflammatory cytokines in B. pseudomallei infected macrophage cells. Collectively, these findings demonstrate the potential of NLP-31 and Y43C5A.3 as anti-B. pseudomallei peptides based on their function as immune modulators.
School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia Bangi, Malaysia.
Mei-Perng
MP
Lim
School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia Bangi, Malaysia.
Mohd
M
Firdaus-Raih
School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan MalaysiaBangi, Malaysia; Malaysia Genome InstituteKajang, Malaysia.
Sheila
S
Nathan
B. pseudomallei; C. elegans; antimicrobial peptides; immunomodulator
Antimicrob Agents Chemother. 1999 Nov;43(11):2648-56
10543742
Nature. 2000 Nov 16;408(6810):325-30
11099033
J Microbiol Methods. 2001 Mar 1;44(2):121-9
11165341
Gene. 2001 Jan 24;263(1-2):103-12
11223248
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10892-7
11535834
Biochem J. 2002 Jan 15;361(Pt 2):221-30
11772394
Nature. 2002 Jan 24;415(6870):389-95
11807545
Curr Biol. 2002 Aug 6;12(15):1317-9
12176360
J Immunol. 2002 Oct 1;169(7):3883-91
12244186
Nature. 2003 Jan 16;421(6920):231-7
12529635
Development. 1992 Nov;116(3):755-66
1289064
Clin Infect Dis. 2004 Mar 15;38(6):864-70
14999632
Nat Immunol. 2004 May;5(5):488-94
15048112
Int J Med Microbiol. 2004 Apr;293(7-8):549-55
15149030
Genome Res. 2004 Oct;14(10B):2162-8
15489339
J Infect Dis. 2005 Nov 15;192(10):1845-50
16235187
Nat Rev Microbiol. 2006 Jul;4(7):529-36
16778838
Clin Microbiol Rev. 2006 Jul;19(3):491-511
16847082
Curr Opin Pharmacol. 2006 Oct;6(5):468-72
16890021
Diagn Microbiol Infect Dis. 2007 Jul;58(3):263-70
17350202
Protein Sci. 2007 Sep;16(9):1969-76
17766389
Nat Protoc. 2008;3(2):163-75
18274517
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W197-201
18463136
PLoS Pathog. 2008 Jul 18;4(7):e1000105
18636113
Bioinformatics. 2008 Sep 15;24(18):2101-2
18662927
Nucleic Acids Res. 2009 Jan;37(Database issue):D933-7
18957441
BMC Microbiol. 2008 Nov 26;8:205
19036162
Trends Immunol. 2009 Mar;30(3):131-41
19217824
Int J Antimicrob Agents. 2009 Oct;34(4):309-14
19577435
FEBS J. 2009 Nov;276(22):6483-96
19817856
J Immunol. 2010 Mar 1;184(5):2539-50
20107187
Expert Rev Anti Infect Ther. 2010 Mar;8(3):325-38
20192686
FEBS Lett. 2010 Apr 16;584(8):1543-8
20214904
Clin Ther. 2010 Aug;32(8):1437-45
20728758
BMC Complement Altern Med. 2010 Sep 02;10:47
20813024
PLoS One. 2011 Mar 07;6(3):e16707
21408228
Biochem Mol Biol Educ. 2006 Jul;34(4):255-61
21638687
Trends Genet. 1990 Jan;6(1):22-5
2183414
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
21890895
Int J Antimicrob Agents. 2012 Jan;39(1):39-44
22005071
J Biol Chem. 2012 Feb 10;287(7):4544-51
22158870
Curr Pharm Des. 2012;18(6):807-19
22236127
Peptides. 2012 Apr;34(2):283-9
22306477
Front Microbiol. 2012 Feb 16;3:53
22355295
N Engl J Med. 2012 Sep 13;367(11):1035-44
22970946
Virulence. 2012 Oct 1;3(6):485-96
23076282
Antimicrob Agents Chemother. 2013 Jan;57(1):220-8
23089755
Future Microbiol. 2012 Dec;7(12):1389-99
23231488
Biochim Biophys Acta. 2013 Mar;1828(3):944-55
23246973
BMC Microbiol. 2013 Apr 09;13:77
23570569
Environ Microbiol Rep. 2011 Apr;3(2):278-85
23761261
PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2267
23785532
PLoS One. 2013 Jun 18;8(6):e66557
23825543
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2307
23875042
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15067-72
23980181
PLoS One. 2013 Oct 02;8(10):e75488
24098387
Pharmaceuticals (Basel). 2013 Nov 28;6(12):1543-75
24287494
Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):197-204
25169965
Front Microbiol. 2015 Apr 10;6:290
25914690
BMC Microbiol. 2015 Nov 06;15:259
26545875
J Appl Microbiol. 2016 Jun;120(6):1449-65
26678028
J Clin Invest. 1989 Aug;84(2):553-61
2668334
Appl Microbiol Biotechnol. 2016 May;100(9):4073-83
26837216
Pharmaceuticals (Basel). 2010 Apr 27;3(5):1296-1303
27713302
Biochemistry. 1974 Feb 12;13(4):714-23
4855765
J Med Chem. 1993 Apr 30;36(9):1203-9
8487258
Infect Immun. 1996 Mar;64(3):782-90
8641782
J Med Chem. 1996 Nov 8;39(23):4540-6
8917641
Protein Eng. 1997 Jan;10(1):1-6
9051728
Biochim Biophys Acta. 1997 Jul 5;1327(1):119-30
9247173
Biochem Biophys Res Commun. 1998 Mar 6;244(1):253-7
9514864